Endocrinology Medical News about colorectal cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Metabolic syndrome and risk of subsequent colorectal cancer
World Journal of Gastroenterology, 11/09/09

Pais R et al. – The physiopathological mechanism that links metabolic syndrome and colorectal cancer is mostly related to abdominal obesity and insulin resistance. Population and experimental studies demonstrated that hyperinsulinemia, elevated C–peptide, elevated body mass index, high levels of insulin growth factor–1, low levels of insulin growth factor binding protein–3, high leptin levels and low adiponectin levels are all involved in carcinogenesis. Understanding the pathological mechanism that links metabolic syndrome and its components to carcinogenesis has a major clinical significance and may have profound health benefits on a number of diseases including cancer, which represents a major cause of mortality and morbidity in these societies.

<< Previous
Restoration of reversed whole PTH/intact PTH ratio and reduction...

Next >>
Growth in children with cystic fibrosis-related diabetes